Xvivo Perfusion AB's total assets for Q3 2025 were kr2.38B, a decrease of -0.43% from the previous quarter. SE:XVIVO total liabilities were kr283.45M for the fiscal quarter, a -4.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.